Hint mode is switched on Switch off

Rocket Pharmaceuticals, ordinary share
RCKT, US77313F1066

Add a stock to WL
Choose all Reset all
Rocket Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Inotek Pharmaceuticals is a clinical-stage, publicly traded, biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. The company was founded in 1999 and ...
Inotek Pharmaceuticals is a clinical-stage, publicly traded, biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. The company was founded in 1999 and is headquartered in Lexington, Massachusetts.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Rocket Pharmaceuticals Inc. (formerly: Inotek Pharmaceuticals Corporation)
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RCKT
  • Placement
    25.01.2018
  • Lock up period
    180
  • Number of papers
    5,500,000
  • Volume of raised funds
    72.88 mln USD
  • Placement share
    14.26%
  • Final placement price
    13.25 USD
  • Price change since placement date
    -79.25%
  • By capitalization
    511.16 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RCKT
  • Placement
    29.11.2018
  • Lock up period
    180
  • Number of papers
    3,550,000
  • Volume of raised funds
    55.03 mln USD
  • Placement share
    8%
  • Final placement price
    15.5 USD
  • Price change since placement date
    -82.26%
  • By capitalization
    687.48 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RCKT
  • Placement
    11.12.2019
  • Lock up period
    180
  • Number of papers
    3,820,000
  • Volume of raised funds
    85 mln USD
  • Placement share
    7.05%
  • Final placement price
    22.25 USD
  • Price change since placement date
    -87.64%
  • By capitalization
    1,205.37 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RCKT
  • Placement
    04.10.2022
  • Lock up period
    180
  • Number of papers
    72,637,894
  • Volume of raised funds
    100.3 mln USD
  • Placement share
    9.36%
  • Final placement price
    14.75 USD
  • Price change since placement date
    -81.36%
  • By capitalization
    1,071.41 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

07/05/2026 Rocket Pharmaceuticals: And Exhibit 99.1 Attached Hereto Is Intended To Be Furnished And Shall Not Be Deemed “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934 (the “exchange Act”) Or Otherwise Subject To The Liabilities Of That Section, Nor Shall It Be Deemed Incorporated By Reference In Any Filing Under The Securities Act Of 1933 Or The Exchange Act, Except As Expressly Set Forth By Specific Reference In Such Filing, Financial Statements And Exhibits
26/04/2026 Rocket Pharmaceuticals: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
10/03/2026 Rocket Pharmaceuticals: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Financial Statements And Exhibits
03/10/2025 Rocket Pharmaceuticals: Other Events
11/09/2025 Rocket Pharmaceuticals: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.